Company Search:
Advanced Search
Sponsored Links
Sanofi S.A. - ADR Company Snapshot
Sanofi S.A. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other companies in this sector in UNITED STATES : Bristol-Myers Squibb Company (2020 sales of $42.52 billion of which 28% was Prioritized Brands-Revlimid), Pfizer Inc. ($41.91 billion of which 26% was Oncology), and GlaxoSmithKline plc ($44.07 billion of which 50% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2020, sales at Sanofi S.A. were $42.87 billion. This is a very small increase of 1.9% versus 2019, when the company's sales were $42.06 billion. This was the fourth straight year of sales growth at Sanofi S.A.. Sales of Vaccines saw an increase that was more than double the company's growth rate: sales were up 7.0% in 2020, from $6.41 billion to $6.85 billion. Sanofi S.A. also saw significant increases in sales in Pharmaceuticals (up 2.5% to $29.45 billion) . Not all segments of Sanofi S.A. experienced an increase in sales in 2020: sales of Consumer Healthcare fell 3.8% to $5.04 billion.
  Stock Performance Chart for Sanofi S.A. - ADR
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 49.36
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 5.9%  
4 Weeks 1.6%   52 Weeks 10.1%  
Sanofi S.A. - ADR Key Data:
  Ticker: SNY Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 42,871,585,250
(Year Ending Jan 2021).
Employees: 99,412
  Currency: U.S. Dollars Market Cap: 123,468,171,392
  Fiscal Yr Ends: December Shares Outstanding: 2,501,381,106
  Share Type: Actions Ordinaires Closely Held Shares: 278,893,788
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.